01. Ukubuka konke
Ngo-Okthoba 8, embukisweni wezemithi ka-2024 CHI World Worldwide ehleliwe eMilan. Njengomunye wemicimbi ebaluleke kakhulu yonyaka emkhakheni wezemithi womhlaba, kwaheha ababambiqhaza abavela emazweni angu-166 nasezifundeni. Ngababukeli abangaphezu kuka-2 400 kanye nababekhona abangama-62,000, lo mbukiso wahlanganisa amamitha-skwele angama-160,000. Ngesikhathi somcimbi, kwaqhutshelwa izingqungquthela nezinkundla ezingaphezu kuka-100, ekhuluma ngezihloko ezahlukahlukene ezisukela kwimithetho yezemithi kanye nokuthuthukiswa kwezidakamizwa okusha kuma-biopharmaceuticals kanye nentuthuko esimeme.
02. Amaphuzu avelele kaJymed
I-Shenzhen jymed Technology Co, Ltd. (Laqishefethi okukhulunywa ngayo njenge- "jymed"), njengomunye wabakhiqizi abakhulu be-ceptide eChina, wethule ubuchwepheshe obusha, imikhiqizo, kanye namathuba okubambisana kumakhasimende omhlaba eMilan Exhibition. Ngesikhathi somcimbi, iqembu le-Jmmed lazidingida ezingxoxweni ezijulile nezinkampani ezenza imithi kanye namakhasimende avela emhlabeni wonke, abelane ngemininingwane ngezinkinga ezibalulekile embonini yama-peptide futhi anikeze imibono ebalulekile ekuthuthukisweni kwesikhathi esizayo.
UJymed uqhosha ipulatifomu yaphesheya kocwaningo kanye nokukhiqizwa kwama-peptides, amakhompiyutha anjenge-peptide-anjenge-peptide, kanye nama-conjugates wezidakamizwa (ama-PDCs). Le nkampani iphethe ubuchwepheshe ekuhlolweni kwe-peptide eyinkimbinkimbi, isisekelo se-cheptide chemistry, kanye nobuchwepheshe obukhulu bokukhiqiza. Isungule ubudlelwano obude obude namabhizinisi amaningi omhlaba wonke adume. UJymed ukholelwa ukuthi ngokwabelana ngemithombo kanye namandla ahambisanayo, kungaletha ithemba nezinketho eziningi ezigulini emhlabeni jikelele.
03. Ukudingida
Iqondiswa yifilosofi ye- "Peptides ngekusasa elingcono," uJymed azoqhubeka nokushayela okusha kwemithi futhi afake isandla empilweni nasenhlalakahleni yeziguli emhlabeni jikelele. Silangazelele ukusebenza nontanga yomhlaba ukwamukela ikusasa eliqhakazile embonini yezemithi.
Mayelana noJymed
I-Shenzhen jymed Technology Co, Ltd. (Laqishefethi okukhulunywa ngayo njengoba uJymed) yasungulwa ngo-2009, enakekela ocwaningweni, ekuthuthukisweni, ekukhiqizeni nasekuthengisweni kwemikhiqizo ehlobene ne-pepttide. Ngama-One Research Center kanye nezisekelo ezintathu ezinkulu zokukhiqiza, i-jymed ingenye yezisebenzi ezinkulu kakhulu zamakhemikhali enzelwe amakhemikhali we-peptide apes in China. Iqembu le-Core R & D liqhosha iminyaka engaphezu kwengu-20 yesipiliyoni embonini ye-pepttide futhi selidlule ngempumelelo ukuhlolwa kwe-FDA kabili. Uhlelo oluphelele lwe-Pepment oluphelele nolusebenzayo lwe-Peptide lwe-Weeptide lunikeza amakhasimende uhla oluphelele lwezinsizakalo, kufaka phakathi ukuthuthukiswa kwama-peptides zokwelapha, ama-peptides wezilwane, ama-antimicrobial ama-peptides, kanye nokubhalisa kanye nokusekelwa kokubhaliswa.
Imisebenzi Eyinhloko Yebhizinisi
1
2. Ama-pettides wezilwane kanye nezimonyo
3. Ama-ceptides ngokwezifiso kanye ne-CRO, CMO, Izinsizakalo ze-OEM
4. Izidakamizwa ze-PDC (i-peptide-radionuclide, i-peptide-molecule - i-molekyuli encane, i-peptide-protein, i-peptide-rna)
Ngaphezu kwe-TirzePatide, uJymed uhambise imidwebo yokubhalisa nge-FDA ne-CDE ngeminye imikhiqizo eminingana ye-API, kufaka phakathi izidakamizwa ezithandwayo ze-API ezithandwayo njengamanje njenge-semaglutide ne-liraglutide. Amakhasimende esikhathi esizayo asebenzisa imikhiqizo kaJymed's azokwazi ukubheka ngqo inombolo yokubhaliswa kwe-CDE noma inombolo yefayela le-DMF lapho uhambisa izinhlelo zokubhalisa ku-FDA noma i-CDE. Lokhu kuzonciphisa kakhulu isikhathi esidingekayo sokulungiselela amadokhumenti okusebenzisa, kanye nesikhathi sokuhlola kanye nezindleko zokubuyekezwa komkhiqizo.
Xhumana nathi
I-Shenzhen jymed Technology Co, Ltd.
Ikheli:Izitezi ze-8 & 9th, zokwakha 1, iShenzhen Biomedical Innovation Industrial Park, No. 14 Jinhui Road, Kengzi Subribistre, Pingzhen
Ucingo:+86 755-266121112
Iwebhusayithi: http://www.jymedtech.com/
Isikhathi Sokuthumela: Oct-18-2024
